Technical Analysis for PIQ - Proteomics International LaboratoriesLtd
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 0.670 | -1.47% | -0.010 |
Earnings due: Nov 22
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Bollinger Band Squeeze | Range Contraction | 0.00% | |
| Stochastic Reached Oversold | Weakness | 0.00% | |
| BB Squeeze + Lower Band Touch | Range Contraction | 0.00% | |
| Gapped Up | Strength | 0.00% | |
| Below Lower BB | Weakness | 0.00% | |
| Lower Bollinger Band Touch | Weakness | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| MACD Bearish Signal Line Cross | Bearish | -1.47% | |
| Bollinger Band Squeeze | Range Contraction | -1.47% | |
| BB Squeeze Started | Range Contraction | -1.47% |
| Alert | Time |
|---|---|
| Possible NR7 | about 12 hours ago |
| Gap Up Partially Closed | about 15 hours ago |
| Up 2% | about 15 hours ago |
| Gapped Up (Partial) | about 16 hours ago |
| Up 1% | about 16 hours ago |
Get a Trading Sidekick!
Proteomics International LaboratoriesLtd Description
Proteomics International Laboratories Limited is a biological research and drug discovery company. The Company operates in three business units unified by a technology platform: Analytical services, which includes specialist contract research, analytical testing and consultancy; Diagnostics, which includes biomarkers of disease and personalized medicine, and Therapeutics, which includes peptide drug discovery from venoms. The Company focuses on the PromarkerD, a proteomics-derived predictive and diagnostic test for diabetic kidney disease. The Company focuses on its diagnostics portfolio using the Promarker platform, and is investigating proteins associated with endometriosis, mesothelioma and other conditions. The Company has a therapeutic drug discovery program targeting new analgesic (painkilling) and antibiotic drug compounds. The Company also has a laboratory to analyze the make-up of biosimilar drugs as being like-for-like with the brand name drugs they seek to replace.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Disease Drugs Clinical Medicine Life Sciences Pound Protein Drug Discovery Laboratory Peptide Proteins Antibiotic Biomarkers Omics Biomarker Personalized Medicine
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 1.4 |
| 52 Week Low | 0.55 |
| Average Volume | 314,403 |
| 200-Day Moving Average | 0.920 |
| 50-Day Moving Average | 0.711 |
| 20-Day Moving Average | 0.707 |
| 10-Day Moving Average | 0.701 |
| Average True Range | 0.027 |
| RSI (14) | 37.89 |
| ADX | 11.3 |
| +DI | 20.939 |
| -DI | 27.011 |
| Chandelier Exit (Long, 3 ATRs) | 0.708 |
| Chandelier Exit (Short, 3 ATRs) | 0.752 |
| Upper Bollinger Bands | 0.742 |
| Lower Bollinger Band | 0.672 |
| Percent B (%b) | -0.03 |
| BandWidth | 9.897 |
| MACD Line | -0.013 |
| MACD Signal Line | -0.011 |
| MACD Histogram | -0.0025 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.715 | ||||
| Resistance 3 (R3) | 0.720 | 0.710 | 0.708 | ||
| Resistance 2 (R2) | 0.710 | 0.699 | 0.708 | 0.705 | |
| Resistance 1 (R1) | 0.690 | 0.691 | 0.685 | 0.685 | 0.702 |
| Pivot Point | 0.680 | 0.680 | 0.678 | 0.678 | 0.680 |
| Support 1 (S1) | 0.660 | 0.669 | 0.655 | 0.655 | 0.638 |
| Support 2 (S2) | 0.650 | 0.661 | 0.648 | 0.635 | |
| Support 3 (S3) | 0.630 | 0.650 | 0.633 | ||
| Support 4 (S4) | 0.625 |
